Segmentation by application further refines the market taxonomy, revealing how clinical intent drives demand. The primary application, enteral nutrition, captures roughly 70 % of the market, as the majority of PEG placements aim to provide sustained caloric support for patients with dysphagia or chronic malnutrition. Medication delivery—including antibiotics, analgesics, and chemotherapeutics—accounts for about 20 % of tube utilization, reflecting the convenience of direct gastric administration in acute care environments. Gastric decompression, employed to evacuate excess gastric contents in postoperative or obstructive cases, represents an estimated 8 % of usage, while palliative care applications, focused on symptom relief and quality‑of‑life improvement, comprise the remaining 2 %. These application‑specific shares are visualized in the accompanying pie chart, and they collectively define the Medical PEG Feeding Tube segmentation landscape by illustrating how each clinical use contributes to overall market volume.